Amanda Phipps, PhD, MPH, BA
Assistant Professor, Epidemiology
Assistant Member, Fred Hutchinson Cancer Research Center
University of Washington
Department of Epidemiology, School of Public Health
Fred Hutchinson Cancer Research Center
1100 Fairview Avenue North, M4-C308
Seattle, WA 98109-1024
Seattle, WA 98109-1024
Dr. Phipps's research interests span the fields of cancer epidemiology, molecular epidemiology, and clinical epidemiology. Her current projects focus on the relationship between modifiable lifestyle factors (e.g., smoking, obesity) and survival in individuals with biologically-distinct subtypes of colorectal cancer. She also has an interest in molecular subtypes of breast cancer, particularly in risk factors for the poor-prognosis triple-negative subtype of breast cancer.
Dr. Phipps co-teaches EPI 515 "Advanced Epidemiologic Methods," offered in the Spring Quarter.
PhD, Epidemiology, University of Washington, SPH 2010
MPH, Epidemiology, University of California (Berkeley) 2003
BA, Biological Sciences, Northwestern University 2001
Phipps AI, Buchanan DD, Makar KW, Burnett-Hartman AN, Coghill AE, Passarelli MN, Baron JA, Ahnen DJ, Win AK, Potter JD, Newcomb PA. BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics. Cancer Epidemiol Biomarkers Prev 2012; 21:1792-8.
Phipps AI, Newcomb PA, Garcia-Albeniz X, Hutter CM, White E, Fuchs CS, Hazra A, Ogino S, Nan H, Ma J, Campbell PA, Figueiredo J, Peters U, Chan AT. Association between colorectal cancer susceptibility loci and survival time after diagnosis. Gastroenterol 2012;143:51-4.e4
Phipps AI, Baron J, Newcomb PA. Pre-diagnostic smoking history, alcohol consumption, and colorectal cancer survival: The Seattle Colon Cancer Family Registry. Cancer 2011;117:4948-57.
Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat G, Rohan TE, Li CI. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 2011;103;470-7.
Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Vitolins M, Kabat G, Rohan TE, Li CI. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 2011;20:454-63.
Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Reproductive and hormonal risk factors for postmenopausal luminal, HER2-overexpressing, and triple-negative breast cancer. Cancer 2008;113(7):1521-6.
In the news
Obesity and Cancer (Quest Online)
Last Reviewed on 3/7/2013